Literature DB >> 2467773

Lymphocyte transformation induced by autologous cells. XVI: Distinctive role of discrete regions of class I MHC antigens in the autologous mixed leucocyte reaction.

J B Innes1, F C Garbrecht, M E Weksler, C Russo.   

Abstract

The role of Class I major histocompatibility complex (MHC) molecules in the autologous (AMLR) and allogeneic mixed lymphocyte reactions was investigated by using monoclonal antibodies (MoAb) directed to polymorphic MHC determinants. The AMLR from subjects with the HLA-A2 phenotype was consistently inhibited by the anti-HLA-A2 MoAb, CR11-351, and the inhibition was dose-dependent and complete even at low antibody concentrations. The allogeneic MLR was inhibited by CR11-351 less than 30% when HLA-A2-bearing cells were used either as stimulator or responder cells. Addition of interleukins 1 and/or 2 to the AMLR in the presence of the inhibiting MoAbs did not restore the proliferative response. These studies suggest that Class I MHC polymorphic determinants, or closely related structures, participate in the induction of the AMLR.

Mesh:

Substances:

Year:  1989        PMID: 2467773      PMCID: PMC1542125     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.

Authors:  J B Innes; M M Kuntz; Y T Kim; M E Weksler
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

2.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

3.  Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Antiserum inhibition of the mixed lymphocyte culture (MLC) interaction. Inhibitory effect of antibodies reactive with HLA-D-associated determinants.

Authors:  D Albrechtsen; B G Solheim; E Thorsey
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

5.  Effect of anti-beta2-microglobulin on antigen and allogeneic lymphocyte-induced proliferation of human lymphocytes.

Authors:  R T McCalmon; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

6.  HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction.

Authors:  R Palacios; G Möller
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

7.  Stimulation of T lymphocytes by autologous non-T lymphoid cells. Participation of HLA-D?

Authors:  B Bergholtz; D Albrechtsen; E Thorsby
Journal:  Tissue Antigens       Date:  1977-07

8.  Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies.

Authors:  C Russo; F Indiveri; V Quaranta; G A Molinaro; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  Specificity and function of a human autologous reactive T cell.

Authors:  P B Hausman; J D Stobo
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

10.  Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

Authors:  R A Vande Stouwe; H G Kunkel; J P Halper; M E Weksler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  1 in total

1.  Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells.

Authors:  Derek J Cavatorta; Hollis N Erb; M Julia Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.